Understanding lung cancer patients’ experiences
Insights from the Global Lung Cancer Coalition’s 2024 global patient experience survey
24th October 2024
This year’s patient experience survey highlighted some encouraging trends including improved involvement score in treatment and care decisions (when compared to the 2023 results) and good support for patients who either chose not to pursue or have no treatment options available.
However, it was also clear from the survey results that more needs to be done to ensure patients get the information they need at the time that it is most useful to them. This is true across the patient journey, including for biomarker testing – where there is still significant confusion amongst patients despite relatively high levels of access to testing.
You can read and download findings from our patient experience survey here.
